Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Holtzbrinck is a privately held German publishing and media group headquartered in Stuttgart. The company operates across scientific and scholarly publishing, education, consumer books, digital media, and news media through major businesses including Springer Nature, Digital Science, Macmillan Publishers, Pan Macmillan, Holtzbrinck Buchverlage, Macmillan Learning, and DIE ZEIT. Its science-related activities are substantial through publishing and research-information services, but it is not a drug developer, biotechnology company, or healthcare operating company. For a biotech analyst, Holtzbrinck is best understood as a media and information-services owner with important exposure to life-science publishing and scientific workflow infrastructure rather than therapeutics, diagnostics, or healthcare delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holtzbrinck Publishing Group.